New! Search for patents from more than 100 countries including Australia, Brazil, Sweden and more

WO2001036478A3 - Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides - Google Patents

Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides Download PDF

Info

Publication number
WO2001036478A3
WO2001036478A3 PCT/US2000/031878 US0031878W WO0136478A3 WO 2001036478 A3 WO2001036478 A3 WO 2001036478A3 US 0031878 W US0031878 W US 0031878W WO 0136478 A3 WO0136478 A3 WO 0136478A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides
polypeptides
bactericidal
methods
permeability increasing
Prior art date
Application number
PCT/US2000/031878
Other languages
French (fr)
Other versions
WO2001036478A2 (en
Inventor
David G Ballinger
Julio J Mulero
Xiaohong Qian
Nancy K Mize
Dana A Haley
Bryan J Boyle
Original Assignee
Hyseq Inc
David G Ballinger
Julio J Mulero
Xiaohong Qian
Nancy K Mize
Dana A Haley
Bryan J Boyle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US44337099A priority Critical
Priority to US09/443,370 priority
Priority to US09/484,597 priority patent/US6129473A/en
Priority to US09/484,597 priority
Priority to US60/183,922 priority
Priority to US18392200P priority
Priority to US19340000P priority
Priority to US60/193,400 priority
Application filed by Hyseq Inc, David G Ballinger, Julio J Mulero, Xiaohong Qian, Nancy K Mize, Dana A Haley, Bryan J Boyle filed Critical Hyseq Inc
Publication of WO2001036478A2 publication Critical patent/WO2001036478A2/en
Publication of WO2001036478A3 publication Critical patent/WO2001036478A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4742Bactericidal/Permeability-increasing protein [BPI]
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2299/00Coordinates from 3D structures of peptides, e.g. proteins or enzymes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change.
    • Y02A90/20Information and communication technologies [ICT] supporting adaptation to climate change. specially adapted for the handling or processing of medical or healthcare data, relating to climate change
    • Y02A90/26Information and communication technologies [ICT] supporting adaptation to climate change. specially adapted for the handling or processing of medical or healthcare data, relating to climate change for diagnosis or treatment, for medical simulation or for handling medical devices

Abstract

The present invention provides novel polynucleotides and proteins encoded by such polynucleotides, along with therapeutic, diagnostic and research utilities for these polynucleotides and proteins. In particular, the polypeptides and polynucleotides of the invention comprise amino acid and nucleic acid sequences of novel bactericidal/permeability increasing-like gene and gene products.
PCT/US2000/031878 1999-11-19 2000-11-20 Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides WO2001036478A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US44337099A true 1999-11-19 1999-11-19
US09/443,370 1999-11-19
US09/484,597 US6129473A (en) 2000-01-18 2000-01-18 Pen or the like with dual illuminating ends
US09/484,597 2000-01-18
US18392200P true 2000-02-22 2000-02-22
US60/183,922 2000-02-22
US19340000P true 2000-03-29 2000-03-29
US60/193,400 2000-03-29

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU17826/01A AU1782601A (en) 1999-11-19 2000-11-20 Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides

Publications (2)

Publication Number Publication Date
WO2001036478A2 WO2001036478A2 (en) 2001-05-25
WO2001036478A3 true WO2001036478A3 (en) 2002-10-31

Family

ID=27497581

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/031878 WO2001036478A2 (en) 1999-11-19 2000-11-20 Methods and compositions relating to bactericidal/permeability increasing factor-like polypeptides and polynucleotides

Country Status (2)

Country Link
AU (1) AU1782601A (en)
WO (1) WO2001036478A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1263957A2 (en) * 2000-04-05 2002-12-11 MERCK PATENT GmbH Human lipid binding protein 1
CA2406087A1 (en) * 2000-04-18 2001-10-25 Merck Patent Gesellschaft Mit Beschraenkter Haftung New lipid binding protein 2
JP2004500833A (en) * 2000-04-18 2004-01-15 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトングMerck Patent Gesellschaft mit beschraenkter Haftung New lipid-binding protein 3
US20050192221A1 (en) * 2003-12-04 2005-09-01 Mccray Paul B.Jr. Methods and compositions related to plunc polypeptides
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003535A1 (en) * 1990-08-13 1992-03-05 Incyte Pharmaceuticals, Inc. Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same
WO1993005797A1 (en) * 1991-09-27 1993-04-01 Incyte Pharmaceuticals, Inc. Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof
WO1995000641A1 (en) * 1993-06-17 1995-01-05 Xoma Corporation Lipopolysaccharide binding protein derivatives
WO1995001428A1 (en) * 1993-07-02 1995-01-12 Incyte Pharmaceuticals, Inc. Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
WO1995005393A2 (en) * 1993-08-18 1995-02-23 Morphosys Gesellschaft Für Proteinoptimierung Mbh Lipopolysaccharide-binding and neutralizing peptides
WO1998058961A1 (en) * 1997-06-20 1998-12-30 Xoma Corporation Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling of related proteins
WO1999006440A1 (en) * 1997-07-31 1999-02-11 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003535A1 (en) * 1990-08-13 1992-03-05 Incyte Pharmaceuticals, Inc. Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same
WO1993005797A1 (en) * 1991-09-27 1993-04-01 Incyte Pharmaceuticals, Inc. Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof
WO1995000641A1 (en) * 1993-06-17 1995-01-05 Xoma Corporation Lipopolysaccharide binding protein derivatives
WO1995001428A1 (en) * 1993-07-02 1995-01-12 Incyte Pharmaceuticals, Inc. Glycosylated and non-glycosylated bactericidal/permeability increasing proteins, and methods for producing same
WO1995005393A2 (en) * 1993-08-18 1995-02-23 Morphosys Gesellschaft Für Proteinoptimierung Mbh Lipopolysaccharide-binding and neutralizing peptides
WO1998058961A1 (en) * 1997-06-20 1998-12-30 Xoma Corporation Bactericidal/permeability-increasing protein: crystallization, x-ray diffraction, three-dimensional structure determination, rational drug design and molecular modeling of related proteins
WO1999006440A1 (en) * 1997-07-31 1999-02-11 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BEAMER L J ET AL: "Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution.", SCIENCE. UNITED STATES 20 JUN 1997, vol. 276, no. 5320, 20 June 1997 (1997-06-20), pages 1861 - 1864, XP002203252, ISSN: 0036-8075 *
M. G. CLAROS ET AL.: "TopPred II: an improved software for membrane protein structure predictions.", CABIOS COMPUTER APPLICATIONS IN THE BIOSCIENCES., vol. 10, no. 6, December 1994 (1994-12-01), IRL PRESS,OXFORD., GB, pages 685 - 686, XP002203253, ISSN: 0266-7061 *

Also Published As

Publication number Publication date
WO2001036478A2 (en) 2001-05-25
AU1782601A (en) 2001-05-30

Similar Documents

Publication Publication Date Title
WO1999033982A3 (en) Human genes and gene expression products i
WO2002014358A3 (en) Novel secreted proteins and their uses
WO2007104529A3 (en) Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling
WO2002014500A3 (en) Human genes and gene expression products
WO2003012099A1 (en) Chondroitin synthase
WO2002050277A3 (en) Protein and nucleic acids encoding same
WO2002032939A3 (en) Secreted proteins and their uses
WO2002048361A3 (en) Novel secreted proteins and their uses
WO2002026801A3 (en) Secreted proteins and their uses
WO2002016578A3 (en) Secreted proteins and methods of using same
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
WO2000041509A3 (en) Polypeptides having acid phosphatase activity and nucleic acids encoding same
WO2001092308A3 (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
WO2002092818A8 (en) Streptococcus agalactiae genome sequence, use for developing vaccines, diagnostic tools, and for identifying therapeutic targets
WO2005077042A3 (en) Albumin fusion proteins
EP1440981A3 (en) Full-length human cdna
WO2003060071A3 (en) Albumin fusion proteins
WO2001072957A3 (en) Fibroblast growth factor-like molecules and uses thereof
WO2004087766A3 (en) Peptabody for cancer treatment
WO2003022222A3 (en) Antisense modulation of protein kinase r expression
WO2004094476A3 (en) Compositions and methods relating to stop-1
WO2005058944A3 (en) Immunogenic peptides fragments of xage-1
TWI253470B (en) Polypeptides for increasing protein phosphorylation and nucleic acid moleculars encoding the same
WO2000044928A3 (en) Materials and methods for the purification of polyelectrolytes
WO2005049806A3 (en) Novel nucleic acids and polypeptides

Legal Events

Date Code Title Description
AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US UZ VN YU ZA ZW

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US US US UZ VN YU ZA ZW

122 Ep: pct application non-entry in european phase